You know the appointment. You list it all — the exhaustion that sleep doesn’t touch, the fog, the weight, the cold, the hair in the drain — and the answer comes back in a sentence you could now recite in your sleep: “Your labs are normal.”
Stop there. Because that thought is wrong, and we can show you why — not with a pep talk, but with the medical literature.
“Normal labs” usually means one number
When most doctors say your thyroid is “normal,” they’re looking primarily at TSH — a signal from your brain to your thyroid. A normal TSH does not confirm that your body is converting enough storage hormone (T4) into the active hormone (T3) your cells actually run on, or that the autoimmune activity underneath Hashimoto’s has settled down.
This has a name in the research — and the name is “enigma”
A group of senior endocrinologists reviewed exactly this problem in the journal Clinical Endocrinology in 2023. The title: “The enigma of persistent symptoms in hypothyroid patients treated with levothyroxine” (Perros et al., 2023). Not “imaginary.” Not “anxiety.” A real, recognized, unresolved medical phenomenon.
The symptom burden is measurable
Studies measuring quality of life in treated hypothyroid patients have found their symptom intensity can run nearly three times that of people without the condition (quality-of-life research, 2024).
Why this matters more than feeling validated
The two gaps the literature keeps circling — conversion (turning T4 into active T3) and the autoimmune attack — are precisely the two things standard treatment leaves untouched. Clinically-dosed selenium has repeated controlled evidence for reducing the very thyroid antibodies that mark the autoimmune attack (Peng et al., 2024 meta-analysis).
That’s the whole reason Thyrolume exists: to support the conversion and the autoimmune side that “your labs are normal” was never measuring — alongside the medication you keep taking.